Tag: Tnf blocker

The FDA issues black box warnings for medications with potentially fatal or serious side effects, and HUMIRA (adalimumab) carries such a warning. Understanding what is the black box warning on HUMIRA is crucial for patients and healthcare providers to weigh the risks against the benefits of this treatment.

The term "Aria drug" is highly ambiguous, as it can refer to the brand-name biologic infusion **Simponi Aria**, or be confused with **ARIA**, an imaging abnormality seen with certain Alzheimer's disease medications. In fact, Simponi Aria is a prescription medication, while ARIA is a documented side effect, representing two completely different pharmaceutical contexts. This guide will explain the difference and provide clarity on both important medical topics.

As of June 2025, Hadlima was designated as an interchangeable biosimilar for Humira, meaning it can be substituted by a pharmacist for the reference product in many US states. Understanding what is the use of Hadlima Pushtouch is crucial for patients managing various autoimmune and autoinflammatory conditions.

As a biosimilar to the popular drug Humira, Yuflyma has a safety and efficacy profile that has been shown to be comparable. Patients considering or beginning treatment with Yuflyma (adalimumab-aaty) should be aware of what are the side effects of the drug yuflyma, which range from mild injection site reactions to more serious risks like infection and malignancy. This article provides a comprehensive overview of the drug's safety profile.

Approved by the FDA in October 2023, Zymfentra is the first and only subcutaneous formulation of infliximab available for maintenance treatment of inflammatory bowel disease (IBD). This innovative medication offers a new pathway for adult patients with moderate to severe Crohn’s disease or ulcerative colitis, providing a convenient, at-home option for long-term therapy.

Over 23.5 million people worldwide are affected by inflammatory diseases, and for many, advanced treatments are necessary to manage symptoms. If you've searched for **what is the drug symphony used for?**, you likely meant Simponi (golimumab), a powerful medication used to treat several of these chronic inflammatory conditions. This article clarifies the common misspelling and explains the therapeutic applications of Simponi (golimumab).

As of 2024, Humira® biosimilars have captured approximately 23% of the adalimumab market. An important drug in this class is Yuflyma. So, **what type of drug is Yuflyma?** It is an interchangeable biosimilar to Humira and belongs to a class of drugs called Tumor Necrosis Factor (TNF) alfa inhibitors.